Irritable Bowel Syndrome Trial, Recruiting (NCT06917963)

Irritable Bowel Syndrome Trial, Recruiting NCT06917963 Sponsor: Medical University of Gdansk Condition: Irritable Bowel Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT06917963 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Irritable Bowel Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years of age or older
You are scheduled to have planned or emergency surgery that will result in the creation of an ileostomy (a surgically made opening from the small intestine through the belly, either as a loop or end opening)
You are able and willing to sign a consent form agreeing to take part
You have no medical reasons that would prevent you from safely taking omeprazole (a common stomach acid medication)

Who may not be able to join:

You are currently pregnant or breastfeeding
You have a known allergy or sensitivity to omeprazole or similar medications (called proton pump inhibitors, which reduce stomach acid)
You have a condition that would make it impossible to accurately measure how much fluid is coming out of your ileostomy each day (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jarosław Kobiela, Professor, MUG Division of General Surgery

Phone: +48516077708

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06917963

Sponsor: Medical University of Gdansk

Phase: Not Applicable

Status: Recruiting

Condition: Irritable Bowel Syndrome

Trial contact: +48516077708

More information: https://clinicaltrials.gov/study/NCT06917963

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years of age or older
You are scheduled to have planned or emergency surgery that will result in the creation of an ileostomy (a surgically made opening from the small intestine through the belly, either as a loop or end opening)
You are able and willing to sign a consent form agreeing to take part
You have no medical reasons that would prevent you from safely taking omeprazole (a common stomach acid medication)

Who may not be able to join:

You are currently pregnant or breastfeeding
You have a known allergy or sensitivity to omeprazole or similar medications (called proton pump inhibitors, which reduce stomach acid)
You have a condition that would make it impossible to accurately measure how much fluid is coming out of your ileostomy each day (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Medical University of Gdansk

Registry

ClinicalTrials.gov

Start date

10 April 2025

Est. completion

1 June 2027

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

difference in mean ileostomy output (ml/24h) between postoperative days (POD) 1-3 between the experimental and control groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov